Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.

Literature DB >> 19454442

Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.

J Herrstedt¹, F Roila.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19454442 DOI： 10.1093/annonc/mdp160

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference.

Authors: Fausto Roila; Jorn Herrstedt; Richard J Gralla; Maurizio Tonato
Journal: Support Care Cancer Date: 2010-12-28 Impact factor: 3.603

2. Synthesis, Characterization and Biocompatibility of N-palmitoyl L-alanine-based Organogels as Sustained Implants of Granisetron and Evaluation of thier Antiemetic Effect.

Authors: Hala Bakr El-Nassan; Aliaa Nabil ElMeshad; Walaa Wadie; Rabab H Sayed
Journal: Pharm Res Date: 2018-05-29 Impact factor: 4.200

3. Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting.

Authors: Henning Burmeister; Stefan Aebi; Cristina Studer; Martin F Fey; Oliver Gautschi
Journal: Support Care Cancer Date: 2011-01-14 Impact factor: 3.603

4. Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study.

Authors: Felipe Melo Cruz; Daniel de Iracema Gomes Cubero; Patrícia Taranto; Tatiana Lerner; Andrea Thaumaturgo Lera; Michele da Costa Miranda; Mariana da Cunha Vieira; Angelo Bezerra de Souza Fêde; Fernanda Schindler; Mércia Maleckas Carrasco; Samuel Oliveira de Afonseca; Hélio Pinczowski; Auro del Giglio
Journal: Support Care Cancer Date: 2011-04-05 Impact factor: 3.603

5. Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.

Authors: Daiki Tsuji; Yong-Il Kim; Keisei Taku; Shigeru Nakagaki; Yoshito Ikematsu; Hiromi Tsubota; Masato Maeda; Naoya Hashimoto; Masayuki Kimura; Takashi Daimon
Journal: Support Care Cancer Date: 2011-05-18 Impact factor: 3.603

Review 6. Pharmacokinetic evaluation of fosaprepitant dimeglumine.

Authors: Francheska Colon-Gonzalez; Walter K Kraft
Journal: Expert Opin Drug Metab Toxicol Date: 2010-10 Impact factor: 4.481

7. Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors.

Authors: George Dranitsaris; Sasha Mazzarello; Stephanie Smith; Lisa Vandermeer; Nathaniel Bouganim; Mark Clemons
Journal: Support Care Cancer Date: 2015-09-17 Impact factor: 3.603